Inclusion Criteria for Clinical Trials in Sepsis
- 1 January 2005
- Vol. 127 (1) , 242-245
- https://doi.org/10.1378/chest.127.1.242
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions ConferenceCritical Care Medicine, 2003
- Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: A randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patientsCritical Care Medicine, 2001
- Definition of sepsisIntensive Care Medicine, 2001
- Dear SIRS, I'm sorry to say that I don't like youCritical Care Medicine, 1997
- Efficacy and Safety of Monoclonal Antibody to Human Tumor Necrosis Factor α in Patients With Sepsis SyndromeJAMA, 1995
- Recombinant Human Interleukin 1 Receptor Antagonist in the Treatment of Patients With Sepsis SyndromeJAMA, 1994
- American College of Chest Physicians/Society of Critical Care Medicine Consensus ConferenceCritical Care Medicine, 1992
- Microbial Infection and the Septic Response in Critical Surgical IllnessArchives of Surgery, 1990
- Sepsis syndromeCritical Care Medicine, 1989
- A Controlled Clinical Trial of High-Dose Methylprednisolone in the Treatment of Severe Sepsis and Septic ShockNew England Journal of Medicine, 1987